collecting duct carcinoma

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:Renal_cell_carcinoma
gptkbp:affects kidney
gptkbp:age adults
gptkbp:associated_with obesity
genetic mutations
smoking
gptkbp:can_metastasize_to liver
lungs
bones
gptkbp:clinical_trial Phase II
Phase III
Phase I
tumor necrosis
vascular invasion
perineural invasion
gptkbp:end_of_life 5-year survival rate low
10-year survival rate low
gptkbp:first_described_by gptkb:1986
gptkbp:gender male
gptkbp:genetic_diversity gptkb:physicist
chromosomal abnormalities
VHL mutation
https://www.w3.org/2000/01/rdf-schema#label collecting duct carcinoma
gptkbp:is_used_for lymphadenopathy
renal mass
gptkbp:occurs_in rare
gptkbp:origin collecting ducts of the kidney
gptkbp:photography gptkb:MRI
CT scan
ultrasound
gptkbp:provides_information_on ASCO guidelines
NCCN guidelines
gptkbp:research_focus gptkb:vaccine
targeted therapy
gptkbp:risk_factor family history
chronic kidney disease
exposure to chemicals
gptkbp:scholarships educational resources available
support groups available
gptkbp:social_responsibility gptkb:clear_cell_carcinoma
biopsy
poor
transitional cell carcinoma
invasive carcinoma
more common in African Americans
high-grade tumor
incidence increasing over time
papillary renal cell carcinoma
poorly differentiated
gptkbp:specialties lymph node dissection
nephrectomy
partial nephrectomy
gptkbp:symptoms weight loss
abdominal pain
hematuria
gptkbp:treatment gptkb:hospital
radiation therapy
chemotherapy
gptkbp:type_of gptkb:healthcare_organization